Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects

Clinical trial NCT01359982 · COMPLETED

Trial details

NCT number: NCT01359982
Sponsor: EpicentRx, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor Lymphomas

Start date: 2011-09-01
Primary completion: 2015-02-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.